Lunch Program: Late-Breaking News and Evidence for Peripheral Intravascular Lithotripsy (IVL)
Come and hear more about the long-term follow-up in the PAD III Randomized Clinical Trial. Understand the latest data, hear about the new Shockwave M5+ catheter and see how IVL can fit into your treatment strategy for calcified PAD.
This is not a CME activity.
CFA Case Series
Peter A. Soukas, M.D., FSCAI, Cardiovascular Institute, Providence, RI